| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Nava Zisapel | Q61129345 |
| P2860 | cites work | Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials | Q22305847 |
| Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia | Q22306021 | ||
| Pineal Melatonin: Cell Biology of Its Synthesis and of Its Physiological Interactions* | Q22306227 | ||
| A default mode of brain function | Q24544311 | ||
| The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis | Q24549774 | ||
| Sleep, circadian rhythms, and the pathogenesis of Alzheimer disease | Q27024779 | ||
| Amyloid-β diurnal pattern: possible role of sleep in Alzheimer's disease pathogenesis | Q27026835 | ||
| The Glymphatic System: A Beginner's Guide | Q28084591 | ||
| Inverted rhythm of melatonin secretion in Smith-Magenis syndrome: from symptoms to treatment | Q28256043 | ||
| Buying time: a rationale for examining the use of circadian rhythm and sleep interventions to delay progression of mild cognitive impairment to Alzheimer's disease | Q28383805 | ||
| Prolonged release melatonin for improving sleep in totally blind subjects: a pilot placebo-controlled multicenter trial | Q28387407 | ||
| The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands | Q28603128 | ||
| Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives | Q28661706 | ||
| The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research | Q29547257 | ||
| Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory | Q29614724 | ||
| The precuneus: a review of its functional anatomy and behavioural correlates | Q29615024 | ||
| Hypothalamic regulation of sleep and circadian rhythms | Q29619151 | ||
| The memory function of sleep | Q29619446 | ||
| Sleep drives metabolite clearance from the adult brain | Q29620065 | ||
| Sleep-anticipating effects of melatonin in the human brain. | Q30352631 | ||
| A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. | Q30405370 | ||
| Decoupling of the brain's default mode network during deep sleep | Q30484161 | ||
| Self-reported sleep and β-amyloid deposition in community-dwelling older adults | Q30571257 | ||
| The dim light melatonin onset, melatonin assays and biological rhythm research in humans | Q33543309 | ||
| Multimodal techniques for diagnosis and prognosis of Alzheimer's disease | Q33607535 | ||
| Associations of objectively and subjectively measured sleep quality with subsequent cognitive decline in older community-dwelling men: the MrOS sleep study | Q33708830 | ||
| Nonrestorative sleep as a distinct component of insomnia | Q33770438 | ||
| Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial | Q33800161 | ||
| The relationship of ethnicity to the prevalence and management of hypertension and associated chronic kidney disease | Q34012316 | ||
| Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial | Q34033768 | ||
| Default network activity, coupled with the frontoparietal control network, supports goal-directed cognition | Q34036875 | ||
| British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. | Q34135759 | ||
| Melatonin in autism spectrum disorders: a systematic review and meta-analysis. | Q34180346 | ||
| Circadian rhythm sleep disorders: pathophysiology and potential approaches to management | Q34313513 | ||
| Sleep Fragmentation and the Risk of Incident Alzheimer's Disease and Cognitive Decline in Older Persons | Q34354571 | ||
| Sleep and sleep disturbances: biological basis and clinical implications | Q34609054 | ||
| Melatonin for sleep in children with autism: a controlled trial examining dose, tolerability, and outcomes | Q34634252 | ||
| Melatonin receptors: role on sleep and circadian rhythm regulation | Q34716949 | ||
| Decreased slow wave sleep increases risk of developing hypertension in elderly men | Q35223298 | ||
| Sleep duration and sleep quality in relation to 12-year cardiovascular disease incidence: the MORGEN study | Q35406975 | ||
| Efficacy and safety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: a combined analysis of controlled clinical trials | Q35752989 | ||
| Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work Group. | Q36025786 | ||
| Greater risk of Alzheimer's disease in older adults with insomnia | Q36043809 | ||
| Correlates and consequences of chronic insomnia | Q36068875 | ||
| Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial | Q36372805 | ||
| Circadian rhythms: mechanisms and therapeutic implications | Q36702128 | ||
| Sleep disorders and melatonin rhythms in elderly people | Q36886429 | ||
| Sleep quality and preclinical Alzheimer disease | Q36913338 | ||
| Sleep disturbance is associated with cardiovascular and metabolic disorders | Q36989949 | ||
| Nighttime blood pressure in normotensive subjects with chronic insomnia: implications for cardiovascular risk. | Q37212644 | ||
| Comorbid insomnia: current directions and future challenges. | Q37418047 | ||
| Drugs for insomnia | Q38017272 | ||
| Sleep in children with autism spectrum disorder | Q38042257 | ||
| Sleep facilitates clearance of metabolites from the brain: glymphatic function in aging and neurodegenerative diseases | Q38160547 | ||
| Tasimelteon: first global approval | Q38194529 | ||
| Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Disease | Q38418268 | ||
| Effectiveness of Sleep-Based Interventions for Children with Autism Spectrum Disorder: A Meta-Synthesis | Q38750877 | ||
| Pharmacotherapies for sleep disturbances in dementia. | Q39010202 | ||
| Mechanisms linking circadian clocks, sleep, and neurodegeneration | Q39019213 | ||
| Diagnosis and Treatment of Non-24-h Sleep-Wake Disorder in the Blind. | Q39147457 | ||
| Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox | Q39541406 | ||
| Comorbidity of chronic insomnia with medical problems | Q40238715 | ||
| Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease. | Q40477472 | ||
| Randomised clinical trial of the effects of prolonged-release melatonin, temazepam and zolpidem on slow-wave activity during sleep in healthy people | Q41001443 | ||
| Sleep differences among children with autism spectrum disorders and typically developing peers: a meta-analysis | Q41290514 | ||
| Melatonin: role in gating nocturnal rise in sleep propensity | Q41666397 | ||
| THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors | Q42660449 | ||
| A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder | Q43012925 | ||
| Prevalence and treatment of insomnia in the community: results from the Upper Bavarian Field Study | Q44091646 | ||
| Indirect projections from the suprachiasmatic nucleus to the ventrolateral preoptic nucleus: a dual tract-tracing study in rat. | Q44197961 | ||
| Concentrations of serotonin and its related substances in the cerebrospinal fluid in patients with Alzheimer type dementia | Q44240659 | ||
| Impaired nocturnal melatonin secretion in non-dipper hypertensive patients. | Q44405975 | ||
| Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study | Q45204771 | ||
| Plasma melatonin concentrations in hypertensive patients with the dipping and non-dipping blood pressure profile. | Q45255929 | ||
| Poor sleep quality impairs cognitive performance in older adults | Q45767463 | ||
| Late evening brain activation patterns and their relation to the internal biological time, melatonin, and homeostatic sleep debt | Q46839791 | ||
| Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder | Q47666680 | ||
| Sleep disturbance: an emerging opportunity for Alzheimer's disease prevention? | Q47785755 | ||
| The interaction of sleep and amyloid deposition on cognitive performance | Q47788676 | ||
| Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial | Q48243417 | ||
| Disturbed sleep patterns in elders with mild cognitive impairment: the role of memory decline and ApoE ε4 genotype | Q48266332 | ||
| Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's disease. | Q48315165 | ||
| Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer's disease | Q48473771 | ||
| Sleep problems of children with pervasive developmental disorders: correlation with parental stress | Q48495273 | ||
| Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. | Q48667633 | ||
| Sleep and quality of life in the Austrian population | Q48710337 | ||
| A new concept for melatonin deficit: on pineal calcification and melatonin excretion | Q48734979 | ||
| Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II. | Q48755783 | ||
| Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer's type with disturbed sleep-waking | Q48770281 | ||
| Age-related changes in melatonin levels in humans and its potential consequences for sleep disorders | Q48772047 | ||
| Sleep structure in essential hypertensive patients: differences between dippers and non-dippers | Q48812874 | ||
| Endogenous Melatonin Levels and the Fate of Exogenous Melatonin: Age Effects | Q61784266 | ||
| Impaired nocturnal secretion of melatonin in coronary heart disease | Q72262842 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial | Q6936496 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | melatonin | Q180912 |
| circadian rhythm | Q208353 | ||
| hormone | Q11364 | ||
| P577 | publication date | 2018-01-10 | |
| 2018-08-01 | |||
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation |
| Q64074194 | Altered irisin/BDNF axis parallels excessive daytime sleepiness in obstructive sleep apnea patients |
| Q99720357 | Angelman syndrome and melatonin: what can they teach us about sleep regulation |
| Q97531130 | Associations between stressors and difficulty sleeping in critically ill patients admitted to the intensive care unit: a cohort study |
| Q92723958 | Calcium Signaling Pathways: Key Pathways in the Regulation of Obesity |
| Q89615834 | Cellular stress responses and dysfunctional Mitochondrial-cellular senescence, and therapeutics in chronic respiratory diseases |
| Q99575524 | Central and Peripheral Actions of Melatonin on Reproduction in Seasonal and Continuous Breeding Mammals |
| Q61799345 | Cerebrovascular Disease in the Young Adult: Examining Melatonin's Possible Multiple Roles |
| Q89797164 | Cholangiocarcinoma: novel therapeutic targets |
| Q92016428 | Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: A randomized, double-blind, placebo-controlled trial |
| Q92083437 | Deciphering the Molecular Basis of Melatonin Protective Effects on Breast Cells Treated with Doxorubicin: TWIST1 a Transcription Factor Involved in EMT and Metastasis, a Novel Target of Melatonin |
| Q89804356 | Development of a Phytomelatonin-Rich Extract from Cultured Plants with Excellent Biochemical and Functional Properties as an Alternative to Synthetic Melatonin |
| Q92854208 | Dietary Protein and Amino Acid Intake: Links to the Maintenance of Cognitive Health |
| Q89125011 | Exogenous melatonin as a treatment for secondary sleep disorders: A systematic review and meta-analysis |
| Q91973421 | Interaction of melatonin and Bmal1 in the regulation of PI3K/AKT pathway components and cellular survival |
| Q88451231 | Long-Term Cognitive Outcomes After Sepsis: a Translational Systematic Review |
| Q92446994 | Melatonin Prevents Transforming Growth Factor-β1-Stimulated Transdifferentiation of Renal Interstitial Fibroblasts to Myofibroblasts by Suppressing Reactive Oxygen Species-Dependent Mechanisms |
| Q89820946 | Melatonin Reverses the Loss of Stemness Induced by TNF-α in Human Bone Marrow Mesenchymal Stem Cells through Upregulation of YAP Expression |
| Q91707665 | Melatonin Target Proteins: Too Many or Not Enough? |
| Q90371354 | Melatonin in type 2 diabetes mellitus and obesity |
| Q57792133 | Melatonin protects vertebral endplate chondrocytes against apoptosis and calcification via the Sirt1-autophagy pathway |
| Q92733431 | Melatonin-Induced Cytoskeleton Reorganization Leads to Inhibition of Melanoma Cancer Cell Proliferation |
| Q58587207 | Melatonin: An Anti-Tumor Agent in Hormone-Dependent Cancers |
| Q92000682 | Neuromodulation of the Pineal Gland via Electrical Stimulation of Its Sympathetic Innervation Pathway |
| Q64103912 | Pediatric sleep disturbances and treatment with melatonin |
| Q90638313 | Steps Towards Developing Effective Treatments for Neuropsychiatric Disturbances in Alzheimer's Disease: Insights From Preclinical Models, Clinical Data, and Future Directions |
| Q91738516 | The Effect Of Fluvoxamine On Sleep Architecture Of Depressed Patients With Insomnia: An 8-Week, Open-Label, Baseline-Controlled Study |
| Q89990271 | The effect of jet lag on the human brain: A neuroimaging study |
| Q89968898 | The effects of daylight exposure on melatonin levels, Kiss1 expression, and melanoma formation in mice |
| Q89632215 | Virtual discovery of melatonin receptor ligands to modulate circadian rhythms |
| Q113913463 | “LONG COVID”—A hypothesis for understanding the biological basis and pharmacological treatment strategy |
Search more.